Skip to content
Screener

EPS (Diluted) at other companies

3M logo
3MMMM
$1.78+32.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$0.94-10.6%
Biogen logo
BiogenBIIB
$0.66-84.8%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$0.28+75.0%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$0.39+128%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$2.15+23.2%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Income (loss) before income taxes21.4(69.3)32.7(70.9)
Income tax expense7.84.314.64.1
Net income (loss)$13.6$(73.6)$18.1$(75.0)
Basic earnings (loss) per share$0.76$(4.00)$1.02$(4.08)
Diluted earnings (loss) per share$0.76$(4.00)$1.01$(4.08)
Shares used in computing:
Basic earnings (loss) per share17.918.417.818.4
Diluted earnings (loss) per share18.018.417.918.4

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's EPS (diluted)?
Rogers Corporation (ROG) reported EPS (diluted) of $0.76 in Q2 2026.
How has Rogers Corporation's EPS (diluted) changed year-over-year?
Rogers Corporation's EPS (diluted) increased by 119.0% year-over-year, from -$4.00 to $0.76.
What is the long-term trend for Rogers Corporation's EPS (diluted)?
Over 4 years (2021 to 2025), Rogers Corporation's EPS (diluted) has grown at a -11.0% compound annual growth rate (CAGR), from $5.73 to -$3.60.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Rogers Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude